techUK Health and Care Summit 2026

Registration and Networking

Welcome Remarks

Keynote: Jonathan Benger, CEO of NICE

Coffee break

The 10 Year Health Plan is built on three shifts – hospital to community, analogue to digital and treatment to prevention - but digital isn't a parallel workstream to the other two, it's the fundamental shift that makes this transformation possible. To mark the launch of techUK's new report, "From Analogue to Digital: How the UK Tech Sector Can Deliver the 10 Year Health Plan," this panel brings together techUK members who submitted case studies for the report with a system-side perspective on delivery. Chaired by Shane Tickell, Chair of techUK's Health and Social Care Council, the discussion will explore what's already working at scale, where the real barriers to delivery sit, and what government and industry each need to do differently to close the gap between ambition and practice.

This panel brings together techUK members with innovation managers from DHI Scotland to look at why proven solutions so often stall between a successful pilot and system-wide adoption, and what practical steps industry, government and innovation bodies can each take to close that gap. Sponsored by Mills & Reeve, the discussion will draw on real examples of what has (and hasn't) worked in getting innovation to scale, and what needs to change to make scaling the rule rather than the exception.

Lunch break

The technology to improve women's health already exists. From menopause and menstrual health apps to remote monitoring, AI-supported triage and platforms built around endometriosis, fertility and maternity pathways, much of it has already been tested successfully within the NHS. Yet too much of it remains stuck at pilot stage, and the same barriers reappear each time: fragmented commissioning, unclear procurement routes, evidence expectations that shift from one system to the next, and business cases that struggle to survive beyond an initial round of funding.

This panel asks what it will take to break that cycle. Our speakers will start with the art of the possible, setting out what is genuinely available and working today, before turning to the harder question of what industry needs to do differently to earn scale, from evidence generation and interoperability to designing with women rather than for them. The discussion will close on policy, exploring what government, NHS England and regulators must put in place so that the renewed Women's Health Strategy translates into services women can actually access.

BREAKOUT : The Life Sciences Sector Plan sets a bold ambition for the UK - but delivery depends on the infrastructure, data and commercial pathways that turn strategy into results.

This panel looks at what has been achieved in Year One of the Plan, what's needed to make that happen in practice, including the role of the Health Data Research Service in unlocking research and innovation at scale. Bringing together voices from across the sector, speakers will discuss progress so far, the practical barriers still facing life sciences innovators, and where techUK members can help drive delivery forward.

Scotland, Wales and Northern Ireland are each taking their own approach to digital transformation in health and care, often working through similar pressures but reaching different solutions. In this fireside chat, Matt Robinson, techUK's Head of Nations and Regions, sits down with Jonathan Cameron, Deputy Director in the Scottish Government, and Helen Thomas, CEO of Digital Health and Care Wales, to compare notes across the nations - what's working, what's different by design rather than by accident, and what the rest of the UK can learn from how Scotland and Wales are approaching delivery.

Coffee break

AI is already at work across health and care, from imaging and triage to administrative automation, and the question facing the sector has shifted. It is no longer whether these tools can work, but how we govern them well and get the proven ones into routine use at pace. Getting that balance wrong is costly in both directions: regulation that is slow or opaque leaves patients waiting for benefits that already exist, while adoption without proper assurance puts safety and public trust at risk. Industry has been central to working this out. Suppliers building and deploying AI in live clinical settings have surfaced the practical realities of evidence generation, post-market surveillance, procurement and workforce readiness, and that experience is now actively shaping how regulators and national bodies approach the rules. This session draws on that learning to ask what is working, what is still holding deployment back, and where the regulatory framework needs to go next.

Our panel will explore how safety and scale can be pursued together: what meaningful assurance looks like in practice, how the landscape is evolving following the work of the National Commission chaired by Professor Alastair Denniston, and what it will take to move beyond successful pilots to system-wide benefit for patients, clinicians and the wider NHS.

Closing Keynote and Final Remarks

Drinks & Networking